Reduced endowment of the nephrons, the basic functional units of the kidney, is associated with future development of hypertension and even chronic kidney disease (CKD), ultimately leading to end stage renal disease (ESRD), a significant, growing economic health burden in the US. The PI has previously identified that the cap mesenchyme is a multipotent self-renewing nephron progenitor population during mammalian kidney development. It is critical to understand how cap mesenchyme cells are regulated during kidney development in order to develop therapeutic approaches to increase nephron endowment in situations like prematurity or malnutrition. Renal-coloboma syndrome (RCS) is a congenital developmental disorder characterized by renal hypodysplasia with reduced nephron numbers caused by PAX2 mutations. Although Pax2 has been widely recognized as an important factor for kidney development over the past two decades, Pax2 function in the developing kidney has not been investigated in vivo. Our central hypothesis supported by extensive preliminary data is that Pax2 function maintains the nephron lineage by repressing trans-differentiation into interstitial cell fates in the cap mesenchyme. In the Aim 1, we will determine cellular mechanisms for the trans-differentiation by molecular characterization of intermediate and terminally trans-differentiated cell states. We will also test whether Pax2 is sufficient to specify cap mesenchyme. In the Aim 2, we will distinguish Pax2 functions in the cap mesenchyme and differentiating nephron cells by comparing stage-specific Pax2 mutants before and after the onset of nephron differentiation. In the Aim 3, we will test our hypothesis that integrin ?8 activity for maintenance of the nephron lineage, acting downstream of Pax2 in cap mesenchyme cells. Results from our proposed studies will initiate to uncover the genetic networks in nephron progenitor cells regulating the lineage boundary to maintain the nephron compartment during formation of the functional kidney with the full complement of nephrons.

Public Health Relevance

Dialysis and renal transplantation are huge burdens for patients with kidney diseases and their families. Multipotent self-renewing nephron progenitor cells have great potential for regenerative medicine approaches for the treatment of kidney diseases because these cells could be expanded in vitro and provide a cellular resource for disease modeling, toxicity testing and ultimately cellular therapies. Our proposed studies to understand the genetic regulatory mechanisms for nephron progenitor cells are crucial to establish regenerative protocols of cell replacement therapy for kidney abnormalities, which will ultimately eliminate the need of dialysis and renal transplantation for patients with kidney diseases.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Program Officer
Hoshizaki, Deborah K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Naiman, Natalie; Fujioka, Kaoru; Fujino, Mari et al. (2017) Repression of Interstitial Identity in Nephron Progenitor Cells by Pax2 Establishes the Nephron-Interstitium Boundary during Kidney Development. Dev Cell 41:349-365.e3
Kozhemyakina, Elena; Zhang, Minjie; Ionescu, Andreia et al. (2015) Identification of a Prg4-expressing articular cartilage progenitor cell population in mice. Arthritis Rheumatol 67:1261-73
Kobayashi, Akio; Mugford, Joshua W; Krautzberger, A Michaela et al. (2014) Identification of a multipotent self-renewing stromal progenitor population during mammalian kidney organogenesis. Stem Cell Reports 3:650-62
Kusaba, Tetsuro; Lalli, Matthew; Kramann, Rafael et al. (2014) Differentiated kidney epithelial cells repair injured proximal tubule. Proc Natl Acad Sci U S A 111:1527-32
Hung, Chi; Linn, Geoffrey; Chow, Yu-Hua et al. (2013) Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 188:820-30
Campanholle, Gabriela; Mittelsteadt, Kristen; Nakagawa, Shunsaku et al. (2013) TLR-2/TLR-4 TREM-1 signaling pathway is dispensable in inflammatory myeloid cells during sterile kidney injury. PLoS One 8:e68640
Ren, Shuyu; Johnson, Bryce G; Kida, Yujiro et al. (2013) LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1. Proc Natl Acad Sci U S A 110:1440-5
DiRocco, Derek P; Kobayashi, Akio; Taketo, Makoto M et al. (2013) Wnt4/?-catenin signaling in medullary kidney myofibroblasts. J Am Soc Nephrol 24:1399-412